Liver Transplant Surgery Recovery, Weeks 3–6: Wound Healing and Graft Stabilization
Weeks 3–6 after liver transplant surgery make up phase 2 of 4 in a typical 16-week recovery: Wound Healing and Graft Stabilization. Your own surgeon's instructions always come first.
Goals for weeks 3–6
- Lab monitoring continues frequently during this phase, typically two to three times weekly initially, decreasing to weekly by the end of Phase 2. The key values tracked include liver enzymes (AST, ALT, GGT, alkaline phosphatase), bilirubin (total and direct), INR, albumin, creatinine, tacrolimus trough, complete blood count, and metabolic panel. A rising bilirubin or rising liver enzymes after initial improvement is a warning sign that demands investigation — the differential includes rejection, biliary complication, vascular complication, infection (particularly CMV hepatitis), and drug toxicity.
- Rejection in liver transplant is diagnosed by liver biopsy (percutaneous, under imaging guidance) and presents on a spectrum from mild (grade 1, often managed by adjusting immunosuppression) to severe (grade 3, requiring aggressive treatment with high-dose steroids or antithymocyte globulin). The liver is more immunologically tolerant than the kidney, and rejection episodes — when caught early — generally respond well to treatment without permanent graft damage. Some centers perform protocol biopsies at scheduled intervals; others biopsy only for clinical or laboratory suspicion.
- The risk of biliary complications remains significant during this phase. Bile leaks typically present in the first 2 to 4 weeks with bilious drain output, fever, or abdominal pain. Biliary strictures can present later, with gradually rising bilirubin and alkaline phosphatase, and itching. If symptoms suggest a biliary problem, imaging (ultrasound, MRCP) and potentially ERCP (endoscopic retrograde cholangiopancreatography) with stenting will be performed. Patients with T-tubes may undergo T-tube cholangiography to assess the biliary anatomy before the tube is removed (typically at 3 to 6 months). Understanding that biliary complications are a known and treatable part of liver transplant recovery — not a failure — helps patients cope with these events when they occur.
- This phase is where aggressive nutritional rehabilitation begins to yield visible results. As appetite improves (graft function restores the metabolic processes that were suppressed by liver failure) and the gastrointestinal tract recovers from surgery, patients should aim for consistent high-protein meals. Supplemental protein shakes can help meet targets if appetite remains limited. Small, frequent meals (5 to 6 per day) may be better tolerated than 3 large meals. Sodium restriction can typically be eased as ascites resolves and diuretics are tapered. Weight gain during this phase is expected and desired — many patients were significantly underweight at transplant.
- For patients transplanted for alcoholic liver disease, nutritional rehabilitation is particularly important because alcohol-related malnutrition is often severe and multifactorial, involving thiamine deficiency, folate deficiency, magnesium depletion, and pancreatic insufficiency. Vitamin and mineral supplementation should be guided by the transplant team and dietitian.
- For patients transplanted for alcohol-related liver disease (ALD), lifelong absolute abstinence from alcohol is non-negotiable. The transplanted liver is just as vulnerable to alcohol injury as the native liver — perhaps more so, because immunosuppressive medications themselves impose a metabolic burden on the graft. Relapse to alcohol use after liver transplant is associated with accelerated graft fibrosis, rejection, and graft loss.
- Abstinence support should be proactive and multifaceted: formal addiction counseling, mutual support groups (Alcoholics Anonymous or SMART Recovery), relapse prevention therapy, and regular screening by the transplant team. Many transplant centers have addiction medicine specialists integrated into the transplant program. Family involvement in abstinence support is valuable. The transplant team should approach this aspect of care with compassion and without judgment — addiction is a chronic medical condition, not a moral failing, and patients who have undergone the grueling journey of liver transplantation deserve support rather than stigma.
- Walking distance and frequency should increase steadily. By the end of Phase 2, most patients should be walking 20 to 30 minutes daily. Formal physiotherapy or rehabilitation referral is appropriate for patients who were severely deconditioned pre-transplant. Upper body and trunk exercises are limited by the large abdominal wound — no heavy lifting, no crunches or sit-ups, no twisting under load. Breathing exercises and incentive spirometry continue to support pulmonary recovery, particularly in patients who had large-volume ascites pre-transplant (which impaired diaphragmatic excursion).
What to avoid in weeks 3–6
- Continue 5 kg lifting restriction through at least week 8
- No driving until transplant team clearance (typically 6-8 weeks)
- Strict medication adherence
- Infection precautions continue
- Absolute alcohol avoidance (lifelong)
- No NSAIDs, no acetaminophen above 2g/day
- No herbal supplements or new medications without approval
- Sun protection (skin cancer risk begins with immunosuppression)
← Weeks 1–2: Intensive Inpatient and Early Post-Discharge Recovery · Weeks 7–12: Rehabilitation and Functional Recovery →
See the whole recovery timeline →
Follow weeks 3–6 in Surgily
Surgily shows each day's exercises for this phase, lets you log how you feel in 30 seconds and share it with your care team, and tells you clearly when to get help.
Get my recovery plan →